Vulvovaginal Candidiasis in Pregnancy
- 1.3k Downloads
Prevalence studies indicate that Candida species colonize the vagina in at least 20 % of all women, rising to 30 % in pregnancy. Although, some studies concluded that pregnant women were more likely to have symptomatic vaginal infections caused by Candida, yet other studies found a high prevalence of asymptomatic infection only during pregnancy. Most episodes of symptomatic vulvovaginal candidiasis (VVC) occur during the second and third trimesters. The increased risk of VVC in pregnancy is likely sustained by pregnancy-related factors, such as immunologic alterations, increased estrogen levels, and increased vaginal glycogen production. Although evidence is incomplete, there is some emerging data which suggests that candidiasis in pregnancy may be associated with increased risk of pregnancy complications, such as premature rupture of membranes, preterm labor, chorioamnionitis, and congenital cutaneous candidiasis. In contrast to nonpregnant women, there are no formal studies, evaluating the use of long-term suppressive maintenance oral azoles in the treatment of recurrent VVC (RVVC) in pregnancy. Most clinicians do not offer suppressive therapy in pregnancy and prefer to treat individual symptomatic episodes only utilizing a topical imidazole vaginally for 7 days to minimize systemic exposure to medications.
KeywordsVulvovaginal Candidiasis Recurrent Pregnancy
Compliance with Ethics Guidelines
Conflict of Interest
Tina Aguin and Jack Dr Sobel have no conflict of interest.
Human and Animal Rights and Informed Consent
This article does not contain any studies with human or animal subjects performed by the authors.
Papers of particular interest, published recently, have been highlighted as: • Of importance
- 3.Mendling W, Brasch J. Guideline vulvovaginal candidosis (2010) of the German Society for Gynecology and Obstetrics, the Working Group for Infections and Infectimmunology in Gynecology and Obstetrics, the German Society of Dermatology, the Board of German Dermatologists and the German Speaking Mycological Society. Mycoses. 2012;55:1–13.CrossRefPubMedGoogle Scholar
- 8.•Leli C, Mencacci A, Meucci M, Bietolini C, Vitalli M, Farinelli S, et al. Association of pregnancy and Candida vaginal colonization in women with or without symptoms of vulvovaginitis. Minerva Ginecol. 2013;65:303–9. This study found that pregnancy is independently associated with a lower probability of having symptoms of Candida vulvovaginitis. The possible explanation is the modulation of maternal immune system and the anti-inflammatory state present during pregnancy. PubMedGoogle Scholar
- 10.Sobel JD. Genital candidiasis. In: Bodey GP, editor. Candidiasis: pathogenesis, diagnosis and treatment. 2nd ed. New York, NY: Raven; 1993. p. 225–47.Google Scholar
- 12.•Kourtis AP, Read JS, Jamieson DJ. Pregnancy and infection. N Engl J Med. 2014;370:2211–8. This article discusses evolving concepts of immunologic alterations during pregnancy that may help explain the altered severity of and susceptibility of infectious diseases in pregnancy. CrossRefPubMedGoogle Scholar
- 19.Kraus TA, Engel SM, Sperling RS, Kellerman L, Lo Y, Wallenstein S, et al. Characterizing the pregnancy immune phenotype: results of the Viral Immunity and Pregnancy (VIP) study. J Clin Immunol. 2012;32.Google Scholar
- 23.Medawar P. Some immunological and endocrinological problems raised by the evolution of viviparity in vertebrates. Symp Soc Exp Biol. 1953;7:320–38.Google Scholar
- 28.Munoz FM, Bond NH, Maccato M, Pinell P, Hammill HA, Swamy GK, et al. Safety and immunogenicity of Tdap vaccine in healthy pregnant women, safety in their neonates, and effect of maternal immunization on infant immune responses to DTaP vaccine. Presented at the 2nd International Maternal Neonatal Immunization Symposium, Antalya, Turkey, March 1–3, 2013. abstract.Google Scholar
- 33.•Roberts CL, Rickard K, Kotsiou G, Morris JM. Treatment of asymptomatic vaginal candidiasis in pregnancy to prevent preterm birth: an open label pilot randomized controlled trial. BMC Pregnancy Childbirth. 2011;11:18. This pilot study demonstrated a tendency towards a reduction in spontaneous preterm birth among women with asymptomatic candidiasis who were treated with clotrimazole. CrossRefPubMedCentralPubMedGoogle Scholar
- 35.Friebe-Hoffman U, Bender D, Sims C, Rauk P. Candida albicans chorioamnionitis associated with preterm labor and sudden intrauterine demise of one twin, a case report. J Reprod Med. 2000;45:354–6.Google Scholar
- 46.Young GL, Jewell D. Topical treatment for vaginal candidiasis (thrush) in pregnancy. Cochrane Database Syst Rev. 2001.Google Scholar
- 47.United Kingdom National Guideline on the Management of Vulvovaginal Candidiasis (2007). Available at www.bashh.org/documents/1798. (Accessed 4 Dec 2008).
- 48.Young G, Jewell D. Topical treatment for vaginal candidiasis (thrush) in pregnancy. Cochrane Database of Systematic Reviews 2001. Issue 4.Google Scholar
- 50.FDA Drug Safety Communication: use of long-term, high-dose Diflucan (fluconazole) during pregnancy may be associated with birth defects in infants http://www.fda.gov/Drugs/DrugSafety/ucm266030.htm.